Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve Coverage of the Known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial. Angela Branche , Nadine Rouphael , David Diemert , Ann Falsey , Cecilia Losada , Lindsey R Baden , Sharon Frey , Jennifer Whitaker , Susan Little , Evan Anderson , Emmanuel Walter , Richard Novak , Richard Rupp , Lisa Jackson , Tara Babu , Angelica Kottkamp , Annie Luetkemeyer , Lilly Immergluck , Rachel Presti , Martin Backer , Patricia Winokur , Siham Mahgoub , Paul Goepfert , Dahlene Fusco , Elissa Malkin , Jeff Bethony , Edward Walsh , Daniel Graciaa , Hady Samaha , Amy Sherman , Stephen Walsh , Getahun Abate , Zacharoula Oikonomopoulou , Hana El Sahly , Thomas Martin , Satoshi Kamidani , Michael Smith , Benjamin Ladner , Laura Porterfield , Maya Dunstan , Anna Wald , Tamia Davis , Robert Atmar , Mark Mulligan , Kirsten Lyke , Christine Posavad , Megan Meagher , David Stephens , Kathleen Neuzil , Kuleni Abebe , Heather Hill , Jim Albert , Kalyani Telu , Jinjian Mu , Teri Lewis , Lisa Giebeig , Amanda Eaton , Antonia Netzl , Sam Wilks , Sina Tureli , Mamodikoe Makhene , Sonja Crandon , David Montefiori , Mat Makowski , Derek Smith , Seema Nayak , Paul Roberts , John Beigel Research square（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
